RecombinantGRObeta/CXCL2, Human
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


RecombinantGRObeta/CXCL2, Human
Description:
Human GRO-α, GRO-β (MIP-2α), and GRO-γ (MIP-2β) are products of three distinct, nonallelichuman genes. GRO-β and GRO-γ share 90% and 86% amino acid sequence homology, respectively, with GROα. All three isoforms of GRO are CXC chemokines that can signal through the CXCR1 or CXCR2 receptors.GRO expression is inducible by serum or PDGF and/or by a variety of inflammatory mediators, such as IL-1 and TNF, in monocytes, fibroblasts, melanocytes and epithelial cells. In certain tumor cell lines, GRO is expressed constitutively.Similar to other alpha chemokines, the three GRO proteins are potent neutrophil attractants and activators. In addition, these chemokines are also active toward basophils.Recombinant Human GRO beta/CXCL2 produced in E.coli is a single non-glycosylated polypeptide chain containing 74 amino acids. A fully biologically active molecule, rhGRO beta/CXCL2 has a molecular mass of 8.0 kDa analyzed by reducing SDS-PAGE and is obtained by chromatographic techniques at GenScript.Endotoxin:
< 0.2 EU/μg, determined by LAL method.Purity:
> 95% as analyzed by SDS-PAGE.Bioactivity:
The EC50 value of human GRO beta on Caˆ2+ mobilization assay in CHO-K1/Gα15/hCXCR2 cells (human Gα15 and human CXCR2 stably expressed in CHO-K1 cells) is less than 200 ng/ml.Reconstitution:
Reconstituted in ddH2O or PBS at 100 μg/ml.Molecular Weight:
8.0 kDa, observed by reducing SDS-PAGE.Storage Conditions:
Lyophilized recombinant Human GRO beta/CXCL2 remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, Human GRO beta/CXCL2 should be stable up to 1 week at 4°C or up to 3 months at -20°C.Appearance:
Sterile Filtered White lyophilized (freeze-dried) powder.Formulation:
Lyophilized after extensive dialysis against PBS.Host or Source:
Escherichia coli.Recommended Usage:
This material is offered by USA Bioworld biotech for research, laboratory or further evaluation purposes. For research use only.CAS Number:
9000-83-3AA Sequence:
APLATELRCQ CLQTLQGIHL KNIQSVKVKS PGPHCAQTEV IATLKNGQKA CLNPASPMVK KIIEKMLKNG KSN
